Koki Shimizu
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Efficacy of auranofin as an inhibitor of desmoid progression.
Journal: Scientific reports
Published: December 15, 2021
Diffusion-Weighted Magnetic Resonance Imaging Improves the Accuracy of Differentiation of Benign from Malignant Peripheral Nerve Sheath Tumors.
Journal: World neurosurgery
Published: July 07, 2021
Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey.
Journal: Japanese journal of clinical oncology
Published: May 23, 2021
Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Journal: Japanese journal of clinical oncology
Published: April 07, 2020
Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
Journal: Japanese journal of clinical oncology
Published: March 10, 2020
Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review.
Journal: Japanese journal of clinical oncology
Published: January 21, 2020
Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Journal: Japanese journal of clinical oncology
Published: October 03, 2019
MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis.
Journal: Journal of medical imaging and radiation oncology
Published: May 23, 2019
Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.
Journal: Human pathology
Published: June 06, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026